AlphaCrest Capital Management’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-8,353
| Closed | -$1.82M | – | 917 |
|
|
2022
Q3 | $1.82M | Sell |
8,353
-3,776
| -31% | -$824K | 0.11% | 263 |
|
|
2022
Q2 | $2.54M | Sell |
12,129
-2,164
| -15% | -$454K | 0.12% | 219 |
|
|
2022
Q1 | $3.47M | Sell |
14,293
-10,405
| -42% | -$2.52M | 0.19% | 95 |
|
|
2021
Q4 | $6.43M | Buy |
24,698
+12,888
| +109% | +$3.36M | 0.24% | 61 |
|
|
2021
Q3 | $3.11M | Buy |
11,810
+10,874
| +1,162% | +$2.87M | 0.16% | 146 |
|
|
2021
Q2 | $231K | Sell |
936
-30,603
| -97% | -$7.55M | 0.01% | 1172 |
|
|
2021
Q1 | $6.12M | Buy |
31,539
+26,291
| +501% | +$5.1M | 0.34% | 45 |
|
|
2020
Q4 | $1.12M | Sell |
5,248
-3,549
| -40% | -$755K | 0.09% | 282 |
|
|
2020
Q3 | $1.51M | Buy |
8,797
+7,152
| +435% | +$1.23M | 0.16% | 147 |
|
|
2020
Q2 | $316K | Sell |
1,645
-6,875
| -81% | -$1.32M | 0.05% | 606 |
|
|
2020
Q1 | $1.26M | Buy |
8,520
+4,224
| +98% | +$622K | 0.15% | 190 |
|
|
2019
Q4 | $666K | Sell |
4,296
-1,937
| -31% | -$300K | 0.05% | 596 |
|
|
2019
Q3 | $842K | Buy |
+6,233
| New | +$842K | 0.05% | 664 |
|
|
2019
Q2 | – | Sell |
-2,743
| Closed | -$285K | – | 1121 |
|
|
2019
Q1 | $285K | Buy |
+2,743
| New | +$285K | 0.04% | 670 |
|